15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer

Carcinogenesis

Volumn 24, Issue 2, 2003, Pages 243-247

  Wu, Jing ^a,b   Xia, Harry Hua Xiang ^a   Tu, Shui Ping ^a   Fan, Dai Ming ^b   Lin, Marie Chia Mi ^a   Kung, Hsiang Fu ^a   Lam, Shiu Kum ^a   Wong, Benjamin Chun Yu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DECANOIC ACID DERIVATIVE; INDOMETACIN; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; UPREGULATION;

APOPTOSIS; ARACHIDONATE 15-LIPOXYGENASE; BASE SEQUENCE; CAFFEIC ACIDS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DNA PRIMERS; ISOENZYMES; LINOLEIC ACIDS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 0037328659     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/24.2.243     Document Type: Article

References (32)

1. Lauwers,G.Y., Scott,G.V. and Karpeh,M.S. (1995) Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer, 75, 2209-2213.
2. Szabo,I. and Tarnawski,A.S. (2000) Apoptosis in the gastric mucosa, molecular mechanisms, basic and clinical implications. J. Physiol. Pharmacol., 51, 3-15.
3. Husain,S.S., Szabo,I.L., Pai,R., Soreghan,B., Jones,M.K. and Tarnawski,A.S. (2001) MAPK (ERK2) kinase-a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth. Life Sci., 69, 3045-3054.
4. Moragoda,L., Jaszewski,R. and Majumdar,A.P. (2001) Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells. Anticancer Res., 21, 873-878.
5. Roy,H.K., Karoski,W.J., Ratashak,A. and Smyrk,T.C. (2001) Chemoprevention of intestinal tumorigenesis by nabumetone, induction of apoptosis and Bcl-2 downregulation. Br. J. Cancer, 84, 1412-1416.
6. Samaha,H.S., Kelloff,G.J., Steele,V., Rao,C.V. and Reddy,B.S. (1997) Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate and 6-phenylhexyl isothiocyanate, apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res., 57, 1301-1305.
7. Piazza,G., Rahm,A., Finn,T. et al (1997) Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest and p53 induction. Cancer Res., 57, 2452-2459.
8. He,T.C., Chan,T.A., Vogelstein,B. and Kinzler,K.W. (1999) PPAR-δ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell, 99, 335-345.
9. Zhou,X.M., Wong,B.C., Fan,X.M., Zhang,H.B., Lin,M.C., Kung,H.F., Fan,D.M. and Lam,S.K. (2001) Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis, 22, 1393-1397.
10. Zhu,G.H., Wong,B.C., Eggo,M.C., Ching,C.K., Yuen,S.T., Chan,E.Y., Lai,K.C. and Lam,S.K. (1999) Non-steroidal anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc. Br. J. Cancer, 79, 393-400.
11. Zhu,G.H., Wong,B.C., Slosberg,E.D. et al. (2000) Overexpression of protein kinase C-betal isoenzyme suppresses indomethacin-induced apoptosis in gastric epithelial cells. Gastroenterology, 118, 507-514.
12. Williams,C.S. and DuBios,R.N. (1996) Prostagladin endoperoxide synthase, why two isoforms? Am. J. Physiol., 270, G393-G400.
13. Dempke,W., Rie,C., Grothey,A. and Schmoll,H.J. (2001) Cyclooxygenase-2, a novel target for cancer chemotherapy? J. Cancer Res. Clin. Oncol., 127, 411-417.
14. Hanif,R., Pittas,A., Feng,Y. et al. (1996) Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52, 237-245.
15. Elder,D.J., Halton,D.E., Hague,A. and Paraskeva,C. (1997) Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase- (COX-2)-selective nonsteroidal anti-inflammatory drug, independence from COX-2 protein expression. Clin. Cancer Res., 3, 1679-1683.
16. Cuendet,M. and Pezzuto,J.M. (2000) The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol. Drug Interact., 17, 109-157.
17. Giovannucci,E. and Goldin,B. (1997) The role of fat, fatty acids and total energy intake in the etiology of human colon cancer. Am. J. Clin. Nutr., 66, 1564S-1571S.
18. Daret,D., Blin,P. and Larrue,J. (1989) Synthesis of hydroxy fatty acids from linoleic acid by human blood platelets. Prostaglandins, 38, 203-214.
19. Ikawa,H., Kamitani,H. and Calvo,B.F. et al (1999) Expression of 15-lipoxygenase-1 in human colorectal cancer. Cancer Res., 59, 360-366.
20. Shureiqi,I., Wojno,K.J., Poore,J.A. et al. (1985) Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis, 20, 1985-1995.
21. Kamitani,H., Geller,M. and Eling,T. (1998) Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation. J. Biol. Chem., 273, 21569-21577.
22. Shureiqi,I., Chen,D., Lee,J.J. et al. (2000) 15-LOX-1, a novel molecular target of non-steroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J. Natl Cancer Inst., 92, 1136-1142.
23. Shureiqi,I., Chen,D., Lotan,R. et al. (2000) 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res., 60, 6846-6850.
24. Shureiqi,I., Xu,X., Chen,D., Lotan,R., Morris,J.S., Fischer,S.M. and Lippman,S.M. (2001) Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res., 61, 4879-4884.
25. Jiang,X.H., Wong,B.C.Y., Lin,M.C.M., Zhu,G.H., Kung,H.F., Jiang,S.H., Yang,D. and Lam,S.K. (2001) Functional p53 is required for Triptolide-induced apoptosis and AP-1 and Nuclear Factor-ΦB activation in gastric cancer cells. Oncogene, 20, 8009-8018.
26. Heydeck,D., Thomas,L., Schnurr,K., Trebus,F., Thierfelder,W.E., Ihle,J.N. and Kuhn,H. (1998) Interleukin-4 and -13 induce upregulation of the murine macrophage 12/15-lipoxygenase activity, evidence for the involvement of transcription factor STAT6. Blood, 92, 2503-2510.
27. Conrad,D.J. and Lu,M. (2000) Regulation of human 12/15-lipoxygenase by Stat6-dependent transcription. Am. J. Respir. Cell. Mol. Biol., 22, 226-234.
28. Kelavkar,U.P. and Badr,K.F. (1999) Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression, evidence that 15-lipoxygenase is a mutator gene. Proc. Natl Acad. Sci. USA, 96, 4378-4383.
29. Hsi,L.C., Wilson,L., Nixon,J. and Eling,T.E. (2001) 15-Lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway. J. Biol. Chem., 276, 34545-34552.
30. Avis,I., Hong,S.H., Martinez,A., Moody,T., Choi,Y.H., Trepel,J., Das,R., Jett,M. and Mulshine,J.L. (2001) Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J., 15, 2007-2009.
31. Shureiqi.I. and Lippman,S.M. (2001) Lipoxygenase modulation to reverse carcinogenesis. Cancer Res., 61, 6307-6312.
32. Wong,B.C.Y., Wang,W.P., Cho,C.H., Fan,X.M., Lin,M.C.M., Kung,H.F. and Lam,S.K. (2001) 12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells. Carcinogenesis, 22, 1349-1354.